These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 20934121)
21. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens. Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808 [TBL] [Abstract][Full Text] [Related]
22. Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy. Lao-Araya M; Steveling E; Scadding GW; Durham SR; Shamji MH J Allergy Clin Immunol; 2014 Nov; 134(5):1193-5.e4. PubMed ID: 25212194 [No Abstract] [Full Text] [Related]
23. Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy? Witten M; Malling HJ; Blom L; Poulsen BC; Poulsen LK J Allergy Clin Immunol; 2013 Nov; 132(5):1248-1252.e5. PubMed ID: 24035151 [No Abstract] [Full Text] [Related]
24. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis. Rossi RE; Monasterolo G; Coco G; Operti D Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987 [TBL] [Abstract][Full Text] [Related]
25. Fraxinus pollen and allergen concentrations in Ourense (South-western Europe). Vara A; Fernández-González M; Aira MJ; Rodríguez-Rajo FJ Environ Res; 2016 May; 147():241-8. PubMed ID: 26901381 [TBL] [Abstract][Full Text] [Related]
26. Circadian and seasonal variations in subcutaneous allergen immunotherapy reactions. McMurray JC; Waters AM; Macomb CV; Brooks DI; Schwartz DJ Ann Allergy Asthma Immunol; 2021 Nov; 127(5):595-596. PubMed ID: 34380067 [No Abstract] [Full Text] [Related]
27. An Electrostatic-Barrier-Forming Window that Captures Airborne Pollen Grains to Prevent Pollinosis. Takikawa Y; Matsuda Y; Nonomura T; Kakutani K; Kusakari SI; Toyoda H Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28098835 [TBL] [Abstract][Full Text] [Related]
29. Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy. Fujimura T; Kawamoto S Allergol Int; 2015 Oct; 64(4):312-20. PubMed ID: 26433527 [TBL] [Abstract][Full Text] [Related]
30. Cockroach sensitization mitigates allergic rhinoconjunctivitis symptom severity in patients allergic to house dust mites and pollen. He W; Jimenez F; Martinez H; Harper NL; Manoharan MS; Carrillo A; Ingale P; Liu YG; Ahuja SS; Clark RA; Rather CG; Ramirez DA; Andrews CP; Jacobs RL; Ahuja SK J Allergy Clin Immunol; 2015 Sep; 136(3):658-66. PubMed ID: 26026342 [TBL] [Abstract][Full Text] [Related]
31. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination. Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581 [TBL] [Abstract][Full Text] [Related]
33. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide. Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093 [TBL] [Abstract][Full Text] [Related]
34. [A three year survey of the practical application of pollen monitoring in specific allergen immunotherapy]. Myszkowska D; Stobiecki M; Dyga W; Majewska R; Czarnobilska E Przegl Lek; 2013; 70(12):1027-32. PubMed ID: 24720121 [TBL] [Abstract][Full Text] [Related]
35. New clinical documentation on ALK grass allergen tablet. Bachert C Drugs Today (Barc); 2008 Dec; 44 Suppl B():57-60. PubMed ID: 19221621 [No Abstract] [Full Text] [Related]
36. [Pollinosis]. Wortmann F Wien Med Wochenschr; 1989 Apr; 139(6-7):116-20. PubMed ID: 2658337 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Rossi RE; Monasterolo G Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445 [TBL] [Abstract][Full Text] [Related]
38. Association between first airborne cedar pollen level peak and pollinosis symptom onset: a web-based survey. Bando H; Sugiura H; Ohkusa Y; Akahane M; Sano T; Jojima N; Okabe N; Imamura T Int J Environ Health Res; 2015; 25(1):104-13. PubMed ID: 24720339 [TBL] [Abstract][Full Text] [Related]
39. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy? Werfel T J Allergy Clin Immunol; 2009 Nov; 124(5):1003-4. PubMed ID: 19895988 [No Abstract] [Full Text] [Related]
40. [My use of the Association Française d'Etudes des Ambroisies pollen calendar for Lyon-Bron (P. Cour collector)]. Bouteloup F Allerg Immunol (Paris); 1995 Nov; 27(9):326-31. PubMed ID: 8590583 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]